Article 03 May 2024 Do Patent Claims To Methods Of Treatment Cover In Vivo Transformations? United States IP
Article 01 May 2024 Federal Circuit Affirms Obviousness Of Rifaximin Polymorph Patents And Denial Of Motion To Modify Judgment After Post-Trial Patented Indication Carve Out United States IP
Article 08 Sep 2023 Federal Circuit Puts The Onus On Patent Owners To Disclaim Patent Term Or Face Double-Patenting United States IP
Article 22 Sep 2021 N.D. Ill. Finds That A Foreign Parent Corp. May Be Sued Under BPCIA Without The U.S. Subsidiary That Signed And Filed ABLA United States IP
Article 29 Jun 2020 COVID-19 Tuition And Fees Lawsuits: Defending University Practices And Defeating Class Claims United States Litigation
Article 15 Jun 2020 Federal Circuit Affirms Safe Harbor Ruling And $70 Million Award In Amgen Inc. v. Hospira, Inc. United States IP
Article 11 Jun 2020 New Revised USMCA Trade Deal Affects Intellectual Property Rights, But Not Exclusivity Period For Biologics United States IP